24 of the Most Highly Sought Out Clinical Studies in Orlando, Florida

If you’re in the Orlando, FL region and have recently typed in, “highest paid clinical trials near me” into your search engine,  and came up with a whole host of options, you might be wondering which ones are the best to apply to. In joining Conquest Research’s highly sought after clinical trials, you’ll have the rare opportunity to contribute to the medical advancement of healthcare, and make a lasting impact on the breakthroughs of tomorrow. Be a part of something groundbreaking – start the journey today!

Who Is Conquest Research?

Conquest Research is a leading provider of medical research services in the Orlando, FL area. Founded by a leader who’s extremely passionate about advancing the clinical trial process, their mission is to deliver cost-effective, high-quality, and timely clinical research for clients worldwide. With an experienced team of researchers and an accredited lab, Conquest Research provides the highest quality data available, helping to further our understanding of medicines and treatments. Conquest is committed to providing lasting research solutions that help provide better treatment options for patients of today, and the future generations of tomorrow.

What Clinical Trials Are Available Right Now Through Conquest?

If you’re interested in participating only in the “highest paid clinical trials near me”, then the ones in the list below are available through Conquest Research.

Gastrointestinal Clinical Trials

Non-alcoholic Fatty Liver Disease (NASH).  Conquest is looking for volunteers for an investigational trial that evaluates medication designed to treat the NASH form of non-alcoholic fatty liver disease. The study seeks to determine if a new medication is safe and effective in treating NASH, and is available for those who are 18 years of age and have a clinical diagnosis of Non-alcoholic Fatty Liver Disease (NASH).  Those eligible will receive study-related care at no cost, and compensation for time and travel may be available. No medical insurance is required.

Neurological Clinical Trials

Diabetic Peripheral Neuropathy Study.   For those who have a clinical diagnosis of diabetic peripheral neuropathy, Conquest Research is seeking volunteers to participate in an investigational trial that’s evaluating a medication designed to help treat patients suffering from DPN.

Eligibility: This clinical trial is seeking participants aged 18+ who have a clinical diagnosis of diabetic peripheral neuropathy. Those eligible will receive study-related care at no cost, and compensation for time and travel may be available. No medical insurance is required. 

Memory Loss Prevention Study.If you have normal memory and thinking, you may be eligible for this memory loss prevention clinical study. Conquest Research is seeking healthy volunteers who may be at risk for cognitive/functional decline that is related to Alzheimer's disease.

Eligibility: This clinical trial is seeking participants aged 65-80, who have normal thinking and memory. You will receive specialized care throughout the study at no cost, and you may be reimbursed for your time. Health insurance is not required to participate. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

General Memory Screen. If you’re worried about general memory loss and are looking for a free memory screening to check the health of your brain, then sign up for Conquest Research's Memory Screen.  While this test will not diagnose any particular illnesses, it can give you a baseline that you can take back to your own physician.

Migraines. Conquest Research is running multiple clinical studies for Migraines that are in Phases 2-3. Treatments will range from oral and nasal treatments to injections of Botox.  The primary goal of this migraine trial is to evaluate nasal medication that is designed to treat acute migraine attacks.

Eligibility: This clinical trial is seeking participants aged 18+, who have a history of painful migraines for at least 3 months. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Mild Cognitive Impairment (MCI).  This investigational trial evaluates a medication designed to treat patients suffering from mild cognitive impairment (MCI).

Eligibility: This clinical trial is seeking participants who are at least 18 years of age, and have a clinical diagnosis of Mild Cognitive Impairment (MCI). Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Mild to Moderate Alzheimer’s Disease. This investigational trial evaluates a medication designed to treat patients suffering from mild to moderate Alzheimer’s disease.

Eligibility: This clinical trial is seeking participants who are at least 18 years of age, and have a clinical diagnosis of mild to moderate Alzheimer’s disease. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Obsessive Compulsive Disorder. Conquest Research is seeking participants for an investigational trial that is evaluating a medication designed to treat patients who are suffering from obsessive-compulsive disorder. This is a randomized, double-blind, placebo-controlled trial of Adjunctive Troriluzole. 

Eligibility: This clinical trial is seeking participants who are male or female, between the ages of 18-65, who have a current diagnosis of OCD. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Parkinson’s Disease. Conquest Research is partnered with leading medical research facilities to conduct clinical trials on treatments for Parkinson’s disease. If you believe you may fit the eligibility criteria, please sign up here for a screening visit.

Postherpetic Neuralgia.  This investigational trial is evaluating a medication designed to treat patients suffering from Postherpetic Neuralgia – which is a complication of shingles that causes burning pain long after the rash/blisters of shingles have disappeared. This is a Phase 2 Study, double-blind, randomized, placebo-controlled, and is parallel-group. This study is looking to evaluate the efficacy and safety of LX9211 for the treatment of post-shingles pain.

Eligibility: This clinical trial is seeking participants who are at least 18 years of age, and who have the presence of pain after their shingles have healed. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance required

Orthopedic Clinical Trials

Adhesive Capsulitis of the Shoulder.  This investigational trial evaluates a medication designed to treat patients suffering from Adhesive Capsulitis of the Shoulder. The primary aim of the research is to determine the safety and effectiveness of the novel drug candidate. This is a Phase 2, randomized, placebo-controlled, double-blind study. 

Eligibility: This study seeks participants who are at least 18 years of age, and must have idiopathic unilateral adhesive capsulitis (frozen shoulder). Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Hallux Abducto Valgus (Bunions).  Conquest is looking for volunteers for this bunion trial, which seeks to evaluate a medication designed to reduce the pain associated with bunions. It is a randomized, placebo-controlled, double-blind, and multiple-dose study that will look at the efficacy and safety of Dysport for the treatment of bunion pain.

Eligibility: This study seeks participants who are at least 18 years of age, who have a history of painful bunions, and who have no history of diabetes. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Lumbar Disc Herniation.  Conquest is seeking volunteers for a disc herniation trial that is evaluating medication designed to reduce back and leg pain in those with lumbar disc herniation. This is a Phase 3 Multicenter Study that is randomized, double-blind, sham-controlled, and comparative in nature. 

Eligibility: This study seeks participants aged 30 and 70, who have a history of lumbar disc herniation. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Lumbar Disc Degenerative Disease/Chronic Low Back Pain. Conquest is seeking volunteers for a lumbar degenerative disc disease trial that is evaluating medication designed for the treatment of lumbar degenerative disc disease (LDDD) or chronic low back pain (CLBP). This is a Phase 3 Multicenter Study that is randomized, and double-blind, to evaluate the efficacy of the SB-01 injection.

Eligibility: This study seeks participants who are at least 18 years of age, who have had chronic low back pain for more than 6 months, or who are experiencing back pain that is greater than their leg pain. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Osteoarthritis of the Knee. Conquest is seeking volunteers for osteoarthritis that is evaluating medication designed to reduce arthritic symptoms. There are multiple studies running for this, in Phase 2-3, and treatment ranges from topical to stem cell injections.

Eligibility: This study seeks participants who are at least 18 years of age, who have had a history of osteoarthritis of the knee, and who haven’t had a total knee replacement. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Osteoarthritis of the Shoulder. Conquest is seeking volunteers for osteoarthritis that is evaluating medication designed to reduce arthritic symptoms and associated pain. This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of FX006 in patients with Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis.

Eligibility: The study seeks participants who are between the ages of 35 and 80,  who have been diagnosed with either osteoarthritis of the shoulder or shoulder adhesive capsulitis (frozen shoulder), and who are experiencing pain in the associated shoulder joint. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Rheumatology Clinical Trials

Ankylosing Spondylitis. Conquest Research is conducting a clinical trial to evaluate the safety and efficacy of an investigational drug for the treatment of Ankylosing Spondylitis. This is a Phase 3 randomized trial, placebo-controlled, double-blind trial. 

Eligibility: The study seeks participants who are at least 18 years of age, and have a clinical diagnosis of ankylosing spondylitis. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Fibromyalgia. Conquest Research is running an investigational trial evaluating a medication designed to help treat patients suffering from Fibromyalgia. The primary goal of this research is to assess the safety and effectiveness of the novel drug candidate in treating FM symptoms. This is a randomized trial, placebo-controlled, double-blind program. 

Eligibility: The study seeks participants between the ages of 18 and 75, who have been diagnosed with FM. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Gout. Conquest is looking for volunteers for a Randomized, Placebo-Controlled, Double-Blind Study in patients with Gout Refractory – Conventional Therapy. The primary goal of the research is to assess the safety and effectiveness of the novel drug candidate in treating gout symptoms.

Eligibility: This study seeks participants between the ages of 18 and 65, who have been diagnosed with gout and are experiencing gout flare-ups. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Psoriatic Arthritis.  Conquest Research is running a clinical trial to evaluate the safety and efficacy of an investigational drug for the treatment of psoriatic arthritis. 

Eligibility: This study seeks participants who are at least 18 years of age, and have a clinical diagnosis of psoriatic arthritis. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Rheumatoid Arthritis.   Conquest Research is running a clinical trial to evaluate the safety and efficacy of an investigational drug for the treatment of rheumatoid arthritis.

Eligibility: This study seeks participants who are at least 18 years of age, and have a clinical diagnosis of rheumatoid arthritis. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

Other

Abbott COVID-19 Device Trial. Conquest is looking for volunteers for an investigational trial on Abbott’s Covid-19 rapid detection device. The study seeks to evaluate the performance of the device in accurately detecting COVID-19 among patients of all age groups. Those eligible will receive study-related care at no cost; compensation for time and travel may be available. No medical insurance is required.

mRNA Flu Vaccine. Conquest is looking for participants for a research study for a potential mRNA flu vaccine. This clinical study is investigational and is looking to see if the vaccine is safe and can help the body produce antibodies that may help fight off the flu. Participation in this study will help advance a new type of flu vaccine and support current investigational development for other infectious diseases.

Eligibility:65 to 85 who are healthy/have stable chronic conditions, who have received this year’s flu vaccine more than four months ago, and who haven’t received a COVID-19 vaccine in the last month.

RSV Vaccine.  Conquest is looking for volunteers for an RSV Vaccine trial. The primary goal of the research is to evaluate the safety and immunogenicity of the novel vaccine candidate.

Eligibility: The study seeks participants over the age of 60, who have never previously been vaccinated against RSV. Compensation for the successful completion of this trial is available according to the length of involvement.

If you meet the eligibility requirements for any of these studies and are looking to participate in some of the highest-paid clinical studies in the Orlando, FL region, then please check out our website and sign up for a study with us!